查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566843

输尿管通路鞘套市场：按类型、最终用户划分：2024-2033 年全球机会分析与产业预测

Ureteral Access Sheath Market By Type (Fr below 10, Fr 10-12, Fr 13-15) , By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

输尿管通路鞘套市场

2023年输尿管通路鞘套市值为12.936亿美元，预计2035年将达到24.1246亿美元，2024年至2035年的复合年增长率为5.31%。

输尿管通路鞘套是泌尿系统手术中的重要设备，特别用于涉及泌尿道和肾臟的介入。输尿管通路鞘套是一根柔性管，插入输尿管，在输尿管镜检查等微创手术过程中为其他器械（例如雷射或视镜）创建通道。该鞘套允许重复插入和移除而不会损坏器械，这在需要多次干预或长时间手术的情况下非常有用。输尿管通路鞘套可方便地进入肾臟和输尿管，使泌尿系统能够高精度、高效率地执行复杂的手术。研究表明，输尿管通路鞘套透过促进手术期间的冲洗流出来降低术中肾内压力和温度。

肾结石市场的开拓、新兴市场医疗基础设施的改善以及微创手术的快速采用是输尿管通路鞘套市场的主要驱动力。过去几年，由于不健康饮食、肥胖、脱水和代谢紊乱的增加，肾结石病例激增。根据疾病管制与预防中心今年发布的一份情况说明书，美国约有 600 万人美国肾结石。

然而，应用输尿管通路鞘套非常复杂并且需要大量的训练和实践。不正确的安装通常会导致严重的併发症，阻碍市场的开拓。此外，还有多种治疗泌尿系统疾病的替代方法，例如不使用鞘套的肾内逆行手术，因此限制了它们的采用。相较之下，美国泌尿系统协会2024年（AUA2024）年会上展示的一张海报称，术前给予Tamsulosin（一种放鬆前列腺和膀胱颈肌肉的药物）可以改善肾功能，可以用于结石治疗的输尿管通路鞘套。

按部门审查

全球输尿管通路鞘套市场按类型、最终用户和地区细分。依类型划分，市场分为10Fr及以下、10-12Fr、13-15Fr。依最终使用者分为医院、专科诊所和门诊手术中心。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，10Fr 及以下细分市场将在 2023 年占据市场主导地位。

按最终用户划分，专科诊所细分市场将在 2023 年获得较高的市场占有率。

在北美，由于成熟的医疗保健系统和对研发的大量投资，市场强劲。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章尿道通路鞘套市场：依类型

  • 市场概况
  • 10Fr以下
  • 10～12Fr
  • 13～15Fr

第五章输尿管通路鞘套市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科诊所
  • 门诊手术中心

第六章 尿道通路鞘套市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国输尿管通路鞘套市场
    • 加拿大输尿管通路鞘套市场
    • 墨西哥输尿管通路鞘套市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国输尿管通路鞘套市场
    • 法国输尿管通路鞘套市场
    • 英国输尿管通路鞘套市场
    • 义大利输尿管通路鞘套市场
    • 西班牙输尿管通路鞘套市场
    • 其他欧洲输尿管通路鞘套市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本输尿管通路鞘套市场
    • 中国输尿管通路鞘套市场
    • 澳洲输尿管通路鞘套市场
    • 印度输尿管通路鞘套市场
    • 韩国输尿管通路鞘套市场
    • 其他亚太地区输尿管通路鞘套市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西输尿管通路鞘套市场
    • 沙乌地阿拉伯输尿管通路鞘套市场
    • 南非输尿管通路鞘套市场
    • 其他拉丁美洲/中东/非洲输尿管通路鞘套市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Boston Scientific Corporation
  • Cook Group
  • Coloplast Corp.
  • Olympus Corporation
  • Oscor Inc.
  • Karl Storz Endoscopy GmbH
  • Richard Wolf GmbH
  • COGENTIX MEDICAL
  • Becton, Dickinson And Company
  • Envaste Ltd
简介目录
Product Code: A66217

Ureteral Access Sheath Market

The ureteral access sheath market was valued at $1,293.6 million in 2023 and is estimated to reach $2,412.46 million by 2035, exhibiting a CAGR of 5.31% from 2024 to 2035

A ureteral access sheath is crucial equipment in urological procedures specifically used in interventions involving the urinary tract and kidneys. It is a flexible tube inserted into the ureter to form a path for other instruments, such as lasers and scopes, during minimally invasive surgeries such as ureteroscopy. The sheath enables repeated insertion and removal of instruments without causing any harm, which is beneficial in cases with multiple interventions or prolonged procedures. The easy access to the kidney and ureter offered by ureteral access sheath enables urologists to perform complex procedures with high precision and efficiency. According to research, ureteral access sheath lowers intraoperative intrarenal pressure and temperature by enhancing irrigation outflow during surgeries.

Increase in prevalence of kidney stone, developing healthcare infrastructure, and surge in adoption of minimally invasive procedures are the major drivers of the ureteral access sheath market. The cases of kidney stones have surged over the past few years due to unhealthy dietary habits and rise in obesity, dehydration, & metabolic disorders. As per a factsheet released by the Center of Disease Control and Prevention this year, around 6 million individuals are suffering from kidney stone in the U.S. Ureteral access sheaths play a crucial role in the treatment of such diseases, thereby witnessing a boost in demand.

However, the placement of ureteral access sheath is highly complex which requires significant training and practice. Incorrect placement usually leads to severe complications, hence constraining the market development. Moreover, there are several substitute approaches for the treatment of urinary diseases such as retrograde intrarenal surgery that do not use the sheath, hence limiting its adoption. Contrarily, according to a poster presented at the American Urological Association 2024 (AUA 2024) annual meeting, preoperative administration of tamsulosin, a medication which relaxes the prostate & bladder neck muscles, is able to successfully place the ureteral access sheath for treating kidney stones.

Segment Review

The global ureteral access sheath market is segmented into type, end user, and region. By type, the market is divided into Fr below 10, Fr 10-12, and Fr 13-15. On the basis of end user, it is classified into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the Fr below 10 segment dominated the market in 2023.

On the basis of end user, the specialty clinics segment acquired a high market share in 2023.

In North America, the market is robust, owing to mature healthcare system, and significant investments in R&D.

Competition Analysis

The major players operating in the ureteral access sheath market are Boston Scientific, Cook Medical, Coloplast Corp, Olympus Corporation, Karl Storz, Oscor Inc, Richard Wolf, Cogentix Medical, Becton, Dickinson and Company, and Envaste Ltd. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Fr below 10
  • Fr 10-12
  • Fr 13-15

By End User

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Boston Scientific Corporation
    • Cook Group
    • Coloplast Corp.
    • Olympus Corporation
    • Oscor Inc.
    • Karl Storz Endoscopy GmbH
    • Richard Wolf GmbH
    • COGENTIX MEDICAL
    • Becton, Dickinson and Company
    • Envaste Ltd

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: URETERAL ACCESS SHEATH MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Fr Below 10
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Fr 10-12
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Fr 13-15
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: URETERAL ACCESS SHEATH MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospital
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Specialty Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: URETERAL ACCESS SHEATH MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Ureteral Access Sheath Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Ureteral Access Sheath Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Ureteral Access Sheath Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Ureteral Access Sheath Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Ureteral Access Sheath Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Ureteral Access Sheath Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Ureteral Access Sheath Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Ureteral Access Sheath Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Ureteral Access Sheath Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Ureteral Access Sheath Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Ureteral Access Sheath Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. Australia Ureteral Access Sheath Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. India Ureteral Access Sheath Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Ureteral Access Sheath Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Ureteral Access Sheath Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Ureteral Access Sheath Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Ureteral Access Sheath Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Ureteral Access Sheath Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Ureteral Access Sheath Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Cook Group
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Coloplast Corp.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Olympus Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Oscor Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Karl Storz Endoscopy GmbH
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Richard Wolf GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. COGENTIX MEDICAL
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Becton, Dickinson And Company
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Envaste Ltd
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments